Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. (Q48948621)

17 February 2018

title

Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. (English)

1 reference

17 February 2018

0 references

Roger G Spragg

1

1 reference

17 February 2018

Friedemann J H Taut

2

1 reference

17 February 2018

James F Lewis

3

1 reference

17 February 2018

Peter Schenk

4

1 reference

17 February 2018

Clemens Ruppert

5

1 reference

17 February 2018

Nathan Dean

6

1 reference

17 February 2018

Kenneth Krell

7

1 reference

17 February 2018

Andreas Karabinis

8

1 reference

17 February 2018

Andreas Günther

9

1 reference

17 February 2018

language of work or name

English

0 references

publication date

10 December 2010

1 reference

17 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

17 February 2018

volume

183

1 reference

17 February 2018

issue

8

1 reference

17 February 2018

page(s)

1055-1061

1 reference

17 February 2018

Incidence of acute lung injury in the United States.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Bovine surfactant therapy for patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Calf's lung surfactant extract in acute hypoxemic respiratory failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

An expanded definition of the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

Beyond mortality: future clinical research in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1424OC

10.1164/RCCM.201009-1424OC

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

21148720

1 reference

17 February 2018